“100% bioavailability” is the headline of every IV therapy marketing page on the internet. It is technically true. It is also frequently irrelevant. The bioavailability argument is the most frequently invoked, least rigorously examined justification for choosing an IV over a pill. At TrufaMED, our position is that IV therapy has genuine clinical value — in the right patients, for the right indications — and that overstating the bioavailability case does a disservice to patients trying to make informed decisions about their care. This guide separates where IV is meaningfully superior from where oral supplementation is just as effective.
Intravenous delivery bypasses gastrointestinal absorption and delivers 100% of the administered dose to the bloodstream immediately. Oral supplementation is subject to variable absorption depending on the nutrient, gastric pH, gut health, co-ingestion with food, and individual genetic factors. IV is meaningfully superior for patients with malabsorption, severe deficiency, acute volume depletion, or rapid therapeutic window requirements. Oral supplementation is equivalent for routine daily-dose maintenance in patients with normal GI function. Both have a role. The pitch that IV is categorically better for everything is not supported by the clinical data.
Bioavailability is a pharmacokinetic term with a precise definition: the fraction of an administered dose that reaches systemic circulation unchanged. For intravenous administration, bioavailability is 100% by definition — the dose enters the bloodstream directly, bypassing any absorption barriers.
For oral administration, bioavailability is determined by:
A vitamin C oral dose of 1 gram may achieve 50 to 75 percent bioavailability in a healthy adult. A 5 gram oral dose saturates absorption pathways and effective bioavailability drops to roughly 30 percent — the additional dose is largely excreted unabsorbed. Intravenous delivery of 5 grams, by contrast, produces blood concentrations many times higher than any oral dose can achieve. For vitamin C, this difference matters therapeutically. For many other nutrients, it does not.
Patients with surgical or disease-related malabsorption cannot reliably absorb oral micronutrients. The list:
In these populations, oral supplementation is unreliable. IV is the appropriate delivery method — this is not a wellness preference, it is clinical necessity.
When a deficiency has reached a level where correction cannot wait for the slow timeline of oral repletion, IV is appropriate. Examples:
A volume-depleted patient who is also nauseated or vomiting cannot rehydrate orally at adequate speed. A liter of saline IV delivers in 30 to 60 minutes what might take 4 to 8 hours orally, assuming the patient could even keep fluids down.
Some clinical interventions require blood concentrations beyond what oral dosing can produce:
For a healthy adult with normal GI function taking a daily multivitamin for preventive wellness, oral is equivalent to IV and substantially more practical. A patient who needs 400 IU of vitamin D daily does not need an IV. A morning pill works.
Oral vitamin D3 at 2,000 to 5,000 IU daily reliably corrects mild to moderate vitamin D deficiency over 6 to 12 weeks. Loading protocols (50,000 IU weekly for 8 weeks) are well-tolerated orally in most patients. IV vitamin D is not a standard of care for typical deficiency.
For mild to moderate iron deficiency in patients without malabsorption, oral iron (ferrous sulfate, ferrous bisglycinate, iron protein succinylate) effectively raises ferritin over 8 to 12 weeks. IV iron is appropriate when oral has failed, when GI side effects prevent adequate dosing, or when rapid correction is needed — not as first-line in routine cases.
Oral magnesium citrate, glycinate, or threonate at 200 to 400 mg daily effectively corrects mild magnesium depletion. IV magnesium is appropriate for symptomatic deficiency, certain cardiac indications, and as part of specific infusion protocols — not for routine supplementation.
Once an initial correction has been achieved — often via IV in malabsorption patients or severe deficiency — maintenance in patients with normal GI function is typically oral. The long-term management is not IV-dependent in most cases.
The largest category of IV therapy use is not clinical deficiency correction. It is wellness drips — Myers’ Cocktail, hydration, post-exercise recovery — delivered to healthy adults who want to feel better or perform at a higher level.
The bioavailability argument for wellness drips is the weakest. A healthy adult with normal GI function and adequate nutrition is getting most of what they need from food and routine supplementation. The subjective benefit patients report from wellness IV therapy is real, but it is a composite of rapid hydration, micronutrient repletion at the margin, placebo response, and the experience itself — resting, being attended to, the ritual.
This does not mean wellness IV therapy is not worthwhile. Patients derive meaningful subjective benefit and pay willingly for the experience and the effect. It means the scientific case is more modest than the marketing suggests, and patients should make informed decisions.
“IV therapy deserves to be taken seriously as a clinical tool, which means being honest about when it matters and when it does not. Patients who come to us with acute volume depletion, malabsorption anatomy, or confirmed severe deficiency need IV delivery. Patients taking a daily multivitamin do not. Both conversations happen at our clinic.” — Dr. Uri Gedalia, MD, TrufaMED Chief Medical Officer
| Nutrient | Oral Bioavailability (approx) | When IV Is Preferred |
|---|---|---|
| Vitamin C (1g) | 50-75% | High-dose therapeutic protocols (25g+) |
| Vitamin B12 (oral) | 1-5% (normal gut), near-zero in intrinsic-factor deficiency | Neurologic B12 deficiency, gastric bypass, pernicious anemia |
| Magnesium (oxide) | 4% | Symptomatic hypomagnesemia, migraine, cardiac indications |
| Magnesium (glycinate, threonate) | 10-20% | As above, when oral has failed |
| Iron (ferrous sulfate) | 10-20% | Malabsorption, oral intolerance, rapid correction needed |
| Glutathione (oral) | Near-zero (destroyed by GI enzymes) | Essentially always — IV or liposomal oral only |
| Vitamin D3 | ~80% | Severe malabsorption only |
| NAD+ (direct) | Not orally viable; precursors (NMN, NR) are different | Any NAD+ protocol where direct delivery is the goal |
| Amino acids | ~90% in healthy adults | Post-surgical, burn recovery, critical illness |
Every IV ordered at TrufaMED is preceded by a physician review. The decision framework is simple:
This is the standard of practice in a Joint Commission-accredited setting — TrufaMED is Florida’s only Joint Commission-accredited urgent care. It is the same standard we apply across our IV therapy program, urgent care services, and concierge membership tiers.
Many TrufaMED patients use a combined approach: oral supplementation for daily maintenance, IV therapy for acute needs, specific protocols, or high-dose interventions. The IV therapy membership program is designed for this pattern — predictable monthly pricing on a defined IV cadence with the ability to add sessions as clinical need changes. Members receive physician oversight on both the oral and IV components of their regimen.
No. IV is superior in specific clinical scenarios — malabsorption, severe deficiency, rapid correction needs, therapeutic doses oral cannot achieve. For routine maintenance in healthy adults with normal GI function, oral supplementation is equally effective.
Not equivalently. Oral NMN and NR are NAD+ precursors that must be converted to NAD+ in tissues after absorption. Direct IV NAD+ produces blood and cellular concentrations oral precursors do not match. Both have a role; they are not interchangeable.
Traditional oral glutathione is largely destroyed by digestion. Liposomal oral glutathione formulations have improved absorption but still fall short of IV delivery for clinical use. For meaningful glutathione therapy, IV is typically the appropriate route.
Oral vitamin C absorption saturates around 200 mg per hour of intestinal absorption capacity. A single 1-gram oral dose yields roughly 500-750 mg to bloodstream; a 5-gram oral dose yields only modestly more because the excess is excreted unabsorbed. High-dose therapeutic vitamin C (25g+) requires IV.
Usually yes — oral iron (ferrous sulfate or a better-tolerated formulation) is first-line for mild-moderate iron deficiency in patients without malabsorption. IV iron is appropriate when oral has failed, when GI side effects prevent adequate dosing, or when rapid correction is clinically necessary.
Technically accurate, frequently irrelevant. 100% bioavailability only matters if you needed the full dose delivered — which is often not the case in routine wellness. The claim is true but often misused to justify IV therapy that would be equally effective orally.
Yes. A common pattern is IV repletion during an initial correction phase, transitioning to oral maintenance once levels normalize. This is appropriate for iron, vitamin D, and B12 in particular. Physician-guided care ensures the transition is timed correctly.
Not strictly. Most nutrients have oral forms. But some — NAD+, glutathione, and high-dose vitamin C — have oral alternatives that do not reliably achieve the clinical effect of IV delivery. For these, IV is often the more effective choice if the clinical goal requires it.
It depends on the nutrient. Fat-soluble vitamins (A, D, E, K) absorb better with dietary fat. Iron absorbs better on an empty stomach but causes more GI upset. Calcium and iron compete for absorption. A physician or pharmacist can review specific timing for your regimen.
TrufaMED offers comprehensive biomarker panels at the Surfside clinic. Results guide the decision between oral and IV correction and whether any intervention is needed at all.
Serving These Areas
Copyright © 2026 TrufaMED Urgent Care
